Dr. Reddy’s in licenses biosimilar for J&J’s multiple myeloma therapy
Eoneren Dr. Reddy’s (NYSE:RDY) on Thursday announced a licensing agreement with China-based Shanghai Henlius Biotech
Eoneren Dr. Reddy’s (NYSE:RDY) on Thursday announced a licensing agreement with China-based Shanghai Henlius Biotech
Sundry Photography EU regulators have issued a positive opinion for the extension of the market
aprott/iStock via Getty Images President Trump has said he plans to raise or impose new
Mario Tama An attorney representing the U.S. Department of Health & Human Services (HHS) said
Michael Vi/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) traded higher in the premarket on Friday
artisteer/iStock via Getty Images BofA Securities analysts identified the companies with the highest market share
Pgiam/iStock via Getty Images Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation
marchmeena29 BMO Capital Markets strategists listed their top quality stocks for long-term investment, which could
Justin Sullivan A group of claimants who say they developed cancer by using Johnson &
JHVEPhoto The FDA has accepted Alvotech (NASDAQ:ALVO) and Teva’s (NYSE:TEVA) Biologics License Applications for AVT05,